Life Technologies | Ativo Circulante



Current Assets Alterar Data
Ardelyx USD 356.45M 72.35M 2024-12
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Cipla INR 209.45B 15.04B 2024-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 114.83M 12.7M 2024-09
CSL USD 10.77B 622M 2024-06
Galapagos EUR 3.34B 219.98M 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
Grifols EUR 5.73B 404.28M 2024-12
Life Technologies USD 76.32M 13.98M 2024-09
Novartis USD 29.7B 1.56B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
United Therapeutics USD 3.87B 126.5M 2024-12



Life Technologies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.